43 results
8-K
EX-10.1
RCEL
AVITA Medical Inc
18 Oct 23
Preliminary commercial revenue of $13.5 million for the third quarter 2023; full year 2023 guidance confirmed
9:07am
Validity, Etc
SECTION 6.5
Financial Information
SECTION 6.6
No Material Adverse Change
SECTION 6.7
Litigation, Labor Matters and Environmental …
Maintenance of Properties
SECTION 7.4
Insurance
SECTION 7.5
Books and Records
SECTION 7.6
Environmental Law Covenant
SECTION 7.7
Use of Proceeds
SECTION
10-KT
EX-10.10
8cvbylh1jmgo
28 Feb 22
Annual report (with FYE transition)
4:11pm
10-KT
i3b6 stvu3m4lgod
28 Feb 22
Annual report (with FYE transition)
4:11pm
10-KT
EX-14.1
w2v63c5 vwmvy53h
28 Feb 22
Annual report (with FYE transition)
4:11pm
10-KT
EX-10.30
7l55yuyht gajbzqoky
28 Feb 22
Annual report (with FYE transition)
4:11pm
8-K
EX-1.1
ig6tu527 n2bz082hw6q
1 Mar 21
Avita Medical, Inc. Announces Pricing of Its Public Offering of
4:05pm
10-K
mn2cpr a33
27 Aug 20
Annual report
12:00am
10-K
EX-14.1
75ojbrw53az61t
27 Aug 20
Annual report
12:00am
8-K12B
EX-14.1
t0j pr0q5c
30 Jun 20
Notification of registration of securities
9:07am
D
8z4vqruhmf 0w1juyf
27 Nov 19
$15.37M in equity, sold $15.37M, 9 investors
4:25pm